New drug hopes to save legs from amputation in artery disease trial
Disease control
Recruiting now
This study tests a new medicine called APAC that aims to prevent blood clots in people with blocked leg arteries. It includes 42 adults aged 45-85 with severe disease, some of whom will have a procedure to restore blood flow. The goal is to see if APAC is safe and well tolerated,…
Phase: PHASE2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated May 15, 2026 11:56 UTC